Antimicrobial Agents Practice Questions

Q: A postoperative patient developed septicemia and was empirically started on combination chemotherapy by a new resident doctor. However, when the patient did not respond even after 10 days of antibiotic treatment, the review of the charts was done. It was found that the resident doctor had started the combination of antibiotics that was mutually antagonistic in action. Which of the following is the most likely combination that was given?

Ampicillin and Chloramphenicol. ***Ampicillin and Chloramphenicol*** - **Ampicillin** is a **bactericidal** antibiotic that inhibits cell wall synthesis, while **chloramphenicol** is **bacteriostatic** and inhibits protein synthesis. - When combined, the bacteriostatic action of chloramphenicol can antagonize the antimicrobial effect of ampicillin, particularly in infections where rapid bacterial killing is crucial. *Vancomycin and Amikacin* - **Vancomycin** is **bactericidal** (cell wall synthesis inhibitor), and **amikacin** is also **bactericidal** (aminoglycoside, protein synthesis inhibitor). - This combination is generally considered synergistic or additive, especially against gram-positive organisms and certain gram-negative bacteria, rather than antagonistic. *Cephalexin and Gentamicin* - Both **cephalexin** (a cephalosporin) and **gentamicin** (an aminoglycoside) are **bactericidal** antibiotics. - This combination can be synergistic, particularly against gram-negative bacteria, by targeting different bacterial processes (cell wall synthesis and protein synthesis, respectively). *Ciprofloxacin and Piperacillin* - **Ciprofloxacin** (a fluoroquinolone) and **piperacillin** (a penicillin) are both **bactericidal** antibiotics. - This combination is often used empirically to broaden coverage against a wide range of bacteria, exhibiting additive or synergistic effects, and is not typically antagonistic.

Q: In a child admitted with Haemophilus influenzae meningitis, cefotaxime was started instead of ampicillin. Which of the following is the likely reason for this?

H. influenzae strains known to produce Beta lactamase. ***H. influenzae strains known to produce Beta lactamase*** - Many *H. influenzae* strains, particularly in meningitis, produce **beta-lactamase enzymes** that inactivate ampicillin. - **Cefotaxime**, a third-generation cephalosporin, is **stable against beta-lactamases**, making it an effective empirical treatment. *Easier to give* - The route and ease of administration are generally **not the primary factors** in choosing between ampicillin and cefotaxime in a severe infection like meningitis. - Both medications can be administered intravenously, which is standard for meningitis treatment. *It is cheap* - While cost is a consideration in healthcare, **efficacy and clinical outcome** for a life-threatening condition like meningitis take precedence over cost. - Treatment choices are primarily driven by **antimicrobial susceptibility patterns** and patient safety. *H. influenzae strains known to have altered penicillin binding protein* - While **altered penicillin-binding proteins (PBPs)** can lead to resistance in some bacteria (e.g., *Streptococcus pneumoniae*), it is **not the predominant mechanism of resistance** to ampicillin in *H. influenzae*. - **Beta-lactamase production** is the much more common and significant reason for ampicillin resistance in *H. influenzae*.

Q: Which of the following is used in the prophylaxis of meningococcus?

Rifampicin. ***Rifampicin*** - **Rifampicin** is a recommended agent for **chemoprophylaxis** against **meningococcal disease**, especially for close contacts of patients. - It works by eliminating the carriage of *Neisseria meningitidis* in the **nasopharynx**. *Erythromycin* - **Erythromycin** is a **macrolide antibiotic** primarily used for respiratory tract infections and certain skin infections. - It is **not effective** for the prophylaxis of meningococcal disease due to poor penetration into the nasopharynx and varied efficacy against *N. meningitidis*. *Tetracycline* - **Tetracyclines** are broad-spectrum antibiotics, but they are **not typically used** for meningococcal prophylaxis. Resistance is common [1], and other agents are preferred due to better efficacy and lower risk of side effects in this context. *Penicillin* - **Penicillin** is effective for treating **active meningococcal infection** but is **not suitable for prophylaxis**. - It does not consistently eradicate the carrier state of *N. meningitidis* from the nasopharynx, which is essential for prophylaxis.

Q: On chronic use, linezolid leads to which of the following?

Thrombocytopenia. ***Thrombocytopenia*** - **Linezolid** is known to cause **myelosuppression**, particularly **thrombocytopenia**, with prolonged use (typically >2 weeks). - This adverse effect is usually **reversible** upon discontinuation of the drug. - This is the **most characteristic** and **dose-limiting** hematologic toxicity of chronic linezolid therapy. *Deranged LFT* - While **linezolid** can occasionally cause **elevated liver enzymes**, this is a **less common** adverse effect compared to myelosuppression. - **Thrombocytopenia** is far more characteristic of **chronic linezolid use** and is the primary concern requiring monitoring. - Hepatotoxicity with linezolid is typically mild and less dose-limiting than hematologic effects. *Nephrotoxicity* - **Linezolid** is generally considered to have a low risk of **nephrotoxicity** and does not typically cause significant kidney damage. - **Aminoglycosides** or **vancomycin** are examples of antibiotics more commonly associated with nephrotoxic effects. *Ototoxicity* - **Ototoxicity**, characterized by hearing loss or tinnitus, is not a common or recognized side effect of **linezolid** therapy. - This adverse effect is more frequently associated with drugs like **aminoglycosides** or high-dose **loop diuretics**.

Q: What is the recommended duration of erythromycin for the treatment of diphtheria?

14 days. ***14 days*** - The recommended duration for **erythromycin** in treating diphtheria is **14 days** to ensure eradication of *Corynebacterium diphtheriae* and prevent toxin production. - This duration helps to eliminate the carrier state and reduce the risk of transmission to others. *3 days* - A 3-day course of antibiotics is **insufficient** for the complete eradication of *Corynebacterium diphtheriae* in diphtheria. - Such a short duration would likely lead to **treatment failure** and persistence of the infection. *7 days* - While 7 days is a common antibiotic duration for some infections, it is generally considered **too short** for diphtheria treatment. - A 7-day course may not fully eliminate the bacteria, potentially leading to **relapse** or a prolonged carrier state. *30 days* - A 30-day course of erythromycin for diphtheria is **unnecessarily long** and could increase the risk of side effects and antibiotic resistance. - The goal is eradication without excessive drug exposure, which 14 days achieves effectively.

Q: Which of the following antimalarials is a slow-acting schizonticide?

Pyrimethamine. ***Pyrimethamine***- Pyrimethamine is a **folate antagonist** [1, 2] that acts as a **slow-acting schizonticide** [1, 3], primarily inhibiting dihydrofolate reductase in the parasite [1].- Due to its slow onset [1], it is typically used in combination with other faster-acting antimalarials, such as sulfadoxine, for treatment or prophylaxis [1].*Artemether*- Artemether is an **artemisinin derivative**, known for its **rapid action** and potent effect against all erythrocytic stages of *Plasmodium falciparum*.- It is a **fast-acting schizonticide** that causes widespread damage to parasite membranes and proteins.*Mefloquine*- Mefloquine is an antimalarial drug recognized for its **long half-life** and efficacy against multidrug-resistant *Plasmodium falciparum*.- While effective, it is considered of **intermediate speed** compared to the rapid action of artemisinins or the very slow action of drugs like pyrimethamine.*Quinine*- Quinine is a **fast-acting schizonticide** that is effective against the asexual erythrocytic forms of *Plasmodium* parasites.- Although potent, its use is limited by potential adverse effects such as **cinchonism** and a short half-life requiring frequent dosing.

Q: Anaerobic bacteria are intrinsically resistant to which of the following antibiotics?

Aminoglycosides (e.g., gentamicin). ***Aminoglycosides (e.g., gentamicin)*** - Anaerobic bacteria lack the **oxygen-dependent transport systems** necessary to take up aminoglycosides into the bacterial cell. - This results in **intrinsic resistance** because the drug cannot reach its intracellular ribosomal target. *Beta-lactams (e.g., penicillin)* - While some anaerobes (like certain *Bacteroides* species) can be resistant to specific beta-lactams due to **beta-lactamase production**, it's not an intrinsic resistance across all anaerobes to all beta-lactams. - Many anaerobes are **susceptible to penicillin**, especially those that do not produce beta-lactamase, or to beta-lactamase inhibitors combination drugs. *Chloramphenicol (broad-spectrum antibiotic)* - Chloramphenicol is effective against many anaerobic bacteria by inhibiting **protein synthesis**. - Anaerobes are generally **susceptible** to chloramphenicol, and it is not an antibiotic to which they are intrinsically resistant. *Metronidazole (used for anaerobic infections)* - Metronidazole is a **prodrug** that requires anaerobic conditions to become activated. - It is highly effective against most obligate anaerobes and is a common choice for treating **anaerobic infections**, indicating susceptibility, not intrinsic resistance.

Q: Which of the following aminoglycoside antibiotics has the highest risk of causing ototoxicity?

Neomycin. ***Neomycin*** - **Neomycin** has the highest risk of **ototoxicity** among the aminoglycosides due to its significant accumulation in inner ear fluid. - It is typically reserved for **topical** or **oral administration** for local effects (e.g., bowel decontamination) to minimize systemic absorption and ototoxic risk [2]. *Kanamycin* - **Kanamycin** is an aminoglycoside with significant ototoxic potential, especially with prolonged use or high doses [1]. - While ototoxic, its risk is generally considered to be lower than Neomycin, which is rarely used systemically due to toxicity [1]. *Amikacin* - **Amikacin** is an aminoglycoside known for its broad spectrum of activity against resistant gram-negative bacteria, and it also carries a risk of ototoxicity [4]. - It is often used in severe infections, and its risk of ototoxicity is monitored, but it's not as high as neomycin [4]. *Gentamicin* - **Gentamicin** is a commonly used aminoglycoside for treating serious bacterial infections, and ototoxicity is a known adverse effect [3]. - While ototoxic, its relative risk is considered lower than neomycin and comparable to other commonly used aminoglycosides when therapeutic drug monitoring is employed [3].

Q: Why is a regimen of four drugs recommended for a TB patient on the first visit?

To prevent emergence of drug-resistant strains. ***To prevent emergence of drug-resistant strains*** - Using a **four-drug regimen** at the initial stage significantly reduces the likelihood of **Mycobacterium tuberculosis** developing resistance to any single drug. - This strategy ensures that even if a small number of bacteria are naturally resistant to one drug, the other drugs will still be effective in killing them, preventing the proliferation of **resistant strains**. *To minimize treatment duration* - While a multi-drug regimen is effective, its primary goal is not to minimize treatment duration but rather to ensure **eradication of the infection** and prevent resistance. - Treatment duration is determined by the need to kill both actively multiplying and dormant bacteria, which typically takes several months even with multiple drugs. *To reduce bacterial load effectively* - Reducing bacterial load is certainly a goal of TB treatment, but the use of four drugs is specifically aimed at achieving this while simultaneously preventing **drug resistance**. - A single effective drug could reduce bacterial load, but it would quickly lead to the emergence of resistant bacteria, making the long-term goal of **cure** impossible. *None of the options* - This option is incorrect because the primary reason for a **four-drug regimen** in TB treatment is indeed to prevent the emergence of **drug-resistant strains**.

Q: Prolonged use of which drug has been implicated in the causation of subacute myelo-optic neuropathy (SMON)?

Quiniodochlor. ***Quiniodochlor*** - **Quiniodochlor** (also known as clioquinol) is an antimicrobial agent whose prolonged use was historically linked to **subacute myelo-optic neuropathy (SMON)**, particularly in Japan. - SMON is characterized by ascending sensory disturbances, motor weakness, and visual impairment due to damage to the spinal cord and optic nerves. *Diloxanide furoate* - **Diloxanide furoate** is an effective luminal amebicide used for asymptomatic carriers of **Entamoeba histolytica**. - Its primary side effects are mild gastrointestinal disturbances, and it is not associated with neurotoxicity like SMON. *Furazolidone* - **Furazolidone** is a nitrofuran antimicrobial used to treat bacterial and protozoal infections, particularly in the gastrointestinal tract. - While it can cause gastrointestinal upset, peripheral neuropathy, and hemolysis in G6PD-deficient individuals, it is not implicated in SMON. *Emetine* - **Emetine** is an alkaloid used as an anti-amebic agent, typically for severe amebiasis. - Its main toxicities include **cardiac toxicity** (e.g., arrhythmias, heart failure), neuromuscular weakness, and gastrointestinal issues, but not SMON.

Question 1

A postoperative patient developed septicemia and was empirically started on combination chemotherapy by a new resident doctor. However, when the patient did not respond even after 10 days of antibiotic treatment, the review of the charts was done. It was found that the resident doctor had started the combination of antibiotics that was mutually antagonistic in action. Which of the following is the most likely combination that was given?

Accepted Answer

Ampicillin and Chloramphenicol

Answer

Vancomycin and Amikacin

Answer

Cephalexin and Gentamicin

Answer

Ciprofloxacin and Piperacillin

Question 2

In a child admitted with Haemophilus influenzae meningitis, cefotaxime was started instead of ampicillin. Which of the following is the likely reason for this?

Accepted Answer

H. influenzae strains known to produce Beta lactamase

Answer

It is cheap

Answer

Easier to give

Answer

H. influenzae strains known to have altered penicillin binding protein

Question 3

Which of the following is used in the prophylaxis of meningococcus?

Accepted Answer

Rifampicin

Answer

Tetracycline

Answer

Erythromycin

Answer

Penicillin

Question 4

On chronic use, linezolid leads to which of the following?

Accepted Answer

Thrombocytopenia

Answer

Deranged LFT

Answer

Nephrotoxicity

Answer

Ototoxicity

Question 5

What is the recommended duration of erythromycin for the treatment of diphtheria?

Accepted Answer

14 days

Answer

3 days

Answer

7 days

Answer

30 days

Question 6

Which of the following antimalarials is a slow-acting schizonticide?

Accepted Answer

Pyrimethamine

Answer

Artemether

Answer

Mefloquine

Answer

Quinine

Question 7

Anaerobic bacteria are intrinsically resistant to which of the following antibiotics?

Accepted Answer

Aminoglycosides (e.g., gentamicin)

Answer

Beta-lactams (e.g., penicillin)

Answer

Chloramphenicol (broad-spectrum antibiotic)

Answer

Metronidazole (used for anaerobic infections)

Question 8

Which of the following aminoglycoside antibiotics has the highest risk of causing ototoxicity?

Accepted Answer

Neomycin

Answer

Amikacin

Answer

Kanamycin

Answer

Gentamicin

Question 9

Why is a regimen of four drugs recommended for a TB patient on the first visit?

Accepted Answer

To prevent emergence of drug-resistant strains

Answer

To reduce bacterial load effectively

Answer

To minimize treatment duration

Answer

None of the options

Question 10

Prolonged use of which drug has been implicated in the causation of subacute myelo-optic neuropathy (SMON)?

Accepted Answer

Quiniodochlor

Answer

Diloxanide furoate

Answer

Furazolidone

Answer

Emetine

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?